Azitra, Inc. (AZTR) stock
AZTRNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.57−0.04 (-6.20%)
Close on Nov 18, 2026Market cap $34.56MP/E –Yield –
Azitra revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Azitra's revenue for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | -100.0% |
| FY2024 | Dec 31, 2024 | $7.50K | -98.9% |
| FY2023 | Dec 31, 2023 | $686.00K | +141.5% |
| FY2022 | Dec 31, 2022 | $284.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $0 | – |
| Q3 FY2025 | Sep 30, 2025 | $0 | -100.0% |
| Q2 FY2025 | Jun 30, 2025 | $0 | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $7.50K | -95.6% |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $90.00K | +195.1% |
| Q3 FY2023 | Sep 30, 2023 | $310.70K | +540.6% |
| Q2 FY2023 | Jun 30, 2023 | $172.00K | +102.4% |
| Q1 FY2023 | Mar 31, 2023 | $113.30K | – |
| Q4 FY2022 | Dec 31, 2022 | $30.50K | – |
| Q3 FY2022 | Sep 30, 2022 | $48.50K | – |
| Q2 FY2022 | Jun 30, 2022 | $85.00K | – |
See a number that looks wrong?